D-0039-2024 Class III Terminated
FDA drug recall D-0039-2024 was initiated by Amerisource Health Services LLC on Sep 1, 2023 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point. The recall status is terminated (terminated Jul 16, 2024). Affected quantity: 3,344 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 11, 2023
- Initiation Date
- Sep 1, 2023
- Termination Date
- Jul 16, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,344 cartons
Product description
HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC#: 68084-447-01; Individual Dose NDC: 68084-447-11
Reason for recall
Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.
Distribution pattern
Nationwide in the USA
Code information
Lot#: 1007002, Exp 12/31/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0039-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026